Organigram Earnings: Canaccord Raises Target While Others Cut
On April 13th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their second fiscal quarter for 2021. Revenue for the quarter
Read moreOn April 13th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their second fiscal quarter for 2021. Revenue for the quarter
Read moreOn April 12th, Aphria Inc (TSX: APHA) (NASDAQ: APHA) released its fiscal third quarter results. The company reported net revenues
Read moreOn Monday, one of the more bearish Tesla Inc. (NASDAQ: TSLA) analysts flipped bullish, and more than doubled their 12-month
Read moreOn Friday, Canaccord Genuity initiated coverage on MicroStrategy (NASDAQ: MSTR) with a $920 price target and buy rating. Joseph Vafi,
Read moreOn April 8th, Verano Holdings (CSE: VRNO) announced their full year 2020 and fourth quarter results, with the results being
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April 13th before the market open.
Read moreOn April 7th, Curaleaf Holdings (CSE: CURA) announced that they completed $312 million acquisition of related party European company EMMAC
Read moreOn April 6th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they acquired cannabis 2.0 operator The Edibles & Infusions
Read moreAphria Inc (TSX: APHA) (NASDAQ: APHA) is expected to report their fiscal third quarter on April 12th. Analysts have a consensus
Read moreOn March 31st, Greenlane Holdings (NASDAQ: GNLN) announced their fourth quarter and full-year financial results. Additionally, they announced that they
Read more